Novo Nordisk wants to keep its crown leading the weight loss drugs pack—despite outlook downgrades and lawsuits, its CFO has a plan
"The ultimate defence in our industry is in innovation," Knudsen told Fortune in an exclusive interview.
(Fortune, 2025-11-06T08:04:00Z)